Naviguer vers d'autres crypto-monnaies

NVSNovartis AG

Liens rapides

Calculateur de Position

Taille de Position (USD)Effet de Levier

Marge Requise

$10.00

P&L si NVS bouge

+1%+$10.00

+5%+$50.00

+10%+$100.00

Commencez à trader avec un levier de {leverage}x

Novartis AG

NVS

$151.00

+0.00% (24h)

ActionsNiveau CLevier 1000x

Points clés

Dernière mise à jour:: 2026-07-06

•Novartis a accepté d'acquérir la société britannique Myricx Bio pour un montant allant jusqu'à 1,5 milliard de dollars (paiement initial + jalons), avec une clôture prévue au S2 2026 — une transaction contraignante confirmée.
•L'accord cible la technologie NMTi-ADC, renforçant les conjugués anticorps-médicament comme la frontière d'innovation la plus disputée de l'industrie pharmaceutique.
•L'acquéreur (NVS) pourrait faire face à une pression vendeuse à court terme alors que les investisseurs évaluent le risque lié aux jalons ; des transactions similaires antérieures ont entraîné des baisses initiales modestes.
•Les sociétés de biotechnologie axées sur les ADC bénéficient d'une probabilité accrue d'acquisition et d'une pression à la hausse sur les multiples de valorisation.
•La sortie de la biotech britannique valide l'écosystème britannique d'oncologie de précision et fournit un signal positif modéré pour les sociétés de sciences de la vie cotées à Londres et les indices européens de la santé.

Prix et structure du marché

Chargement du graphique...

État du régime de trading

Effet de levier

1000x

(Maximum sur CoinUnited.io)

Volatilité

N/A

Glossaire

Key listed-stock and CFD terms, one line each — so the page is unambiguous for both readers and AI answer engines.

Stock CFD	A contract for difference on a share price — price exposure only, not ownership of the underlying shares.
Extended hours	Pre-market and after-hours trading outside the exchange’s regular session.
Basis risk	The risk that the CFD reference price and the exchange execution price do not move in step.
P/E	Price-to-earnings ratio = share price ÷ earnings per share; a common valuation gauge.
Gross margin	Gross profit ÷ revenue; reflects product-level profitability.
EPS	Earnings per share = net income ÷ diluted shares outstanding.

Dernières pulsations

2026-07-06ActionsHaussier

NVS

Novartis paie jusqu'à 1,5 milliard de dollars pour la biotech britannique Myricx Bio, approfondissant la course aux armements ADC

Comme rapporté par GlobeNewswire et confirmé par la presse financière, Novartis AG a accepté d'acquérir la société britannique Myricx Bio pour un montant allant jusqu'à 1,5 milliard de dollars dans le

Voir toutes les pulsations NVS

Get Started with Novartis AG

Start trading Novartis AG on CoinUnited.io with industry-leading leverage and zero fees.

Trade with Leverage

Trade NVS CFDs with up to 1000x leverage on CoinUnited.io.

Up to 1000x leverage
Zero trading fees
Advanced risk management tools

Trade NVS Now

Explore Stocks

Browse the full stocks market on CoinUnited.io with 125+ instruments.

125+ stocks instruments
Real-time market data
Professional charting tools

Browse Stocks

Learn Stocks Trading

Read our in-depth research and analysis on stocks markets.

Expert market analysis
Technical analysis basics
Daily market insights

Read Our Research

How to Trade Novartis AG: Step-by-Step Guide

Learn how to trade Novartis AG (NVS) on CoinUnited.io with up to 1000x leverageand zero trading fees. Follow this simple step-by-step guide to start CFD trading today.

Create Your CoinUnited.io Account

✓Quick and free registration
✓Email and password setup
✓Two-factor authentication for security

Verify Your Identity

Complete the KYC verification process to unlock full trading features and higher limits.

✓Upload government-issued ID
✓Proof of address document
✓Usually verified within minutes

Deposit Funds

Fund your account using one of the supported deposit methods.

Deposit Methods

•Cryptocurrency deposits (BTC, ETH, USDT)
•Bank transfer available
•No minimum deposit requirement

Find NVS in the Stocks Section

Navigate to the stocks market section and search for NVS. You can trade Novartis AG as a CFD with up to 1000x leverage.

✓Search for "NVS" in the trading platform
✓Select CFD trading mode
✓Review the current price and market data

Place Your Trade

Choose your position direction (long or short), set your leverage, and enter your position size to trade Novartis AG.

✓Long (buy) if you expect NVS to rise
✓Short (sell) if you expect NVS to fall
✓Set stop-loss and take-profit levels

Monitor & Manage Risk

Keep track of your open positions and manage risk with stop-loss orders and position sizing.

✓Monitor P&L in real-time
✓Adjust stop-loss as needed
✓Never risk more than you can afford to lose

Order Types

Market Order

Execute immediately at the current market price. Best for quick entries.

Limit Order

Set a specific price to enter. The order fills only when the market reaches your price.

Stop-Loss Order

Automatically close your position at a specified price to limit potential losses.

Important Tips

• Start with a small position to understand how leverage works
• Always set a stop-loss to protect your capital
• Higher leverage amplifies both gains and losses
• Never invest more than you can afford to lose

Prêt à trader Novartis AG ?

Jusqu'à 1000x de levier

Commencez à trader NVS

symbole

NVS

Marchés

Actions

Secteur

General

Code produit CU

NVS

Étiquettes

Coinbase UK License Multiasset ExpansionCoinbase UK Derivatives Exchange LaunchAI Monetization Revenue Race

Similar Stocks Assets

Explore other stocks instruments in the same sector as Novartis AG. Compare performance and find trading opportunities.

USA Rare Earth, Inc.

$19.24

▲12.4%

Direxion Daily TSLA Bull 2X Shares

$9.79

▲10.1%

MP Materials Corp.

$60.02

▲8.9%

Tempus AI, Inc

$72.73

▲8.8%

ProShares UltraShort Silver

$24.60

▲8.5%

View all General →

À Propos de l'Auteur

CoinUnited.io Research Team

This Novartis AG page is compiled by CoinUnited.io's research team: analysts covering listed equities and global markets, working from primary filings and named third-party data rather than opinion.

Notre Méthodologie de Recherche

Every figure is traced to a primary or named third-party source and dated: financial statements from the company’s SEC filings, institutional ownership from Form 13F, analyst targets from aggregated third-party coverage, and market data from the CoinUnited reference price. The Source Map on this page lists each one with its source and the date we last checked it.

Disclaimer: content is for informational and educational purposes only and is not personalized financial advice. A stock CFD carries significant risk and provides price exposure only, not equity ownership. Always conduct your own research and consult a qualified financial advisor.

Avertissements et Références

Avertissement important sur les risques

A CoinUnited stock CFD gives price exposure to Novartis AG only, not equity ownership: no shareholder voting rights, no dividends, and no settlement in the underlying share.

Leverage magnifies losses as well as gains, and a position can be liquidated long before the underlying share price recovers. The underlying listing trades on exchange hours, so the reference price can gap between sessions.

Les utilisateurs doivent mener leurs propres recherches et consulter des professionnels financiers qualifiés avant de prendre toute décision d’investissement. Les créateurs et opérateurs de cette plateforme déclinent toute responsabilité en cas de pertes financières ou d’autres dommages pouvant résulter de la confiance accordée aux informations fournies.

Leveraged trading is extremely risky and you may lose your entire deposit.

Aperçu de la méthodologie

Figures on this page are compiled from primary and named third-party sources, not produced by a forecasting model. Each one carries its source and date in the Source Map above.

Financial statements: the company’s own SEC filings (10-K / 10-Q), read from XBRL
Market data: the CoinUnited reference price and daily closes
Institutional ownership: SEC Form 13F quarterly filings
Analyst targets: aggregated third-party sell-side coverage — third-party opinion, not CoinUnited’s view
Peer multiples: third-party trailing-twelve-month ratios

CoinUnited does not publish a price forecast or target for Novartis AG.

Dernière révision de la méthodologie :

Prêt à commencer à trader Novartis AG ?

Rejoignez des milliers de traders et commencez votre parcours de trading Novartis AG aujourd'hui. Accédez à des outils de trading avancés et à des frais compétitifs.

Trader NVS/USDT Inscrivez-vous maintenant